Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ).
Fusen Pharmaceutical Co., Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 29, 2025, in Hong Kong. The meeting will address standard business matters such as the adoption of financial statements, re-election of directors, and re-appointment of auditors. Additionally, a special resolution will be considered to authorize the company’s directors to manage share allotments and transfers, potentially impacting the company’s capital structure and shareholder value.
More about Fusen Pharmaceutical Co., Ltd.
Fusen Pharmaceutical Co., Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is involved in the development and distribution of pharmaceutical products, focusing on providing healthcare solutions.
YTD Price Performance: -68.12%
Average Trading Volume: 432,638
Technical Sentiment Signal: Buy
Current Market Cap: HK$187.5M
For detailed information about 1652 stock, go to TipRanks’ Stock Analysis page.